TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

被引:528
作者
Pols, Thijs W. H. [1 ]
Nomura, Mitsunori [1 ]
Harach, Taoufiq [1 ]
Lo Sasso, Giuseppe [1 ]
Oosterveer, Maaike H. [1 ]
Thomas, Charles [1 ]
Rizzo, Giovanni [2 ]
Gioiello, Antimo [3 ]
Adorini, Luciano [2 ]
Pellicciari, Roberto [3 ]
Auwerx, Johan [1 ]
Schoonjans, Kristina [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland
[2] Intercept Pharmaceut, New York, NY 10013 USA
[3] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
BILE-ACID RECEPTOR; NF-KAPPA-B; MICE; PROTEIN; GPBAR1; AGONIST; CELLS; DELETION; LESION;
D O I
10.1016/j.cmet.2011.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The G protein-coupled receptor TGR5 has been identified as an important component of the bile acid signaling network, and its activation has been linked to enhanced energy expenditure and improved glycemic control. Here, we demonstrate that activation of TGR5 in macrophages by 6 alpha-ethyl-23(S)-methylcholic acid (6-EMCA, INT-777), a semisynthetic BA, inhibits proinflammatory cytokine production, an effect mediated by TGR5-induced cAMP signaling and subsequent NF-kappa B inhibition. TGR5 activation attenuated atherosclerosis in Ld/r(-/-)Tgr5(+/+) mice but not in Ld/r(-/-)Tgr5(-/-) double-knockout mice. The inhibition of lesion formation was associated with decreased intraplaque inflammation and less plaque macrophage content. Furthermore, Ld/r(-/-)animals transplanted with Tgr5(-/-) bone marrow did not show an inhibition of atherosclerosis by INT-777, further establishing an important role of leukocytes in INT-777-mediated inhibition of vascular lesion formation. Taken together, these data attribute a significant immune modulating function to TGR5 activation in the prevention of atherosclerosis, an important facet of the metabolic syndrome.
引用
收藏
页码:747 / 757
页数:11
相关论文
共 35 条
[1]   Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 [J].
Arakawa, Masayuki ;
Mita, Tomoya ;
Azuma, Kosuke ;
Ebato, Chie ;
Goto, Hiromasa ;
Nomiyama, Takashi ;
Fujitani, Yoshio ;
Hirose, Takahisa ;
Kawamori, Ryuzo ;
Watada, Hirotaka .
DIABETES, 2010, 59 (04) :1030-1037
[2]   Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists [J].
Evans, Karen A. ;
Budzik, Brian W. ;
Ross, Sean A. ;
Wisnoski, David D. ;
Jin, Jian ;
Rivero, Ralph A. ;
Vimal, Mythily ;
Szewczyk, George R. ;
Jayawickreme, Channa ;
Moncol, David L. ;
Rimele, Thomas J. ;
Armour, Susan L. ;
Weaver, Susan P. ;
Griffin, Robert J. ;
Tadepalli, Sarva M. ;
Jeune, Michael R. ;
Shearer, Todd W. ;
Chen, Zibin B. ;
Chen, Lihong ;
Anderson, Donald L. ;
Becherer, J. David ;
De Los Frailes, Maite ;
Javier Colilla, Francisco .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (24) :7962-7965
[3]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[4]   Macrophage-specific inhibition of NF-κB activation reduces foam-cell formation [J].
Ferreira, Valerie ;
van Dijk, Ko Willems ;
Groen, Albert K. ;
Vos, Rogier M. ;
van der Kaa, Jos ;
Gijbels, Marion J. J. ;
Havekes, Louis M. ;
Pannekoek, Hans .
ATHEROSCLEROSIS, 2007, 192 (02) :283-290
[5]   Structure-Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes [J].
Genet, Cedric ;
Strehle, Axelle ;
Schmidt, Celine ;
Boudjelal, Geoffrey ;
Lobstein, Annelise ;
Schoonjans, Kristina ;
Souchet, Michel ;
Auwerx, Johan ;
Saladin, Regis ;
Wagner, Alain .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :178-190
[6]   Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5 [J].
Herbert, Mark R. ;
Siegel, Dana L. ;
Staszewski, Lena ;
Cayanan, Charmagne ;
Banerjee, Urmi ;
Dhamija, Sangeeta ;
Anderson, Jennifer ;
Fan, Amy ;
Wang, Li ;
Rix, Peter ;
Shiau, Andrew K. ;
Rao, Tadimeti S. ;
Noble, Stewart A. ;
Heyman, Richard A. ;
Bischoff, Eric ;
Guha, Mausumee ;
Kabakibi, Ayman ;
Pinkerton, Anthony B. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) :5718-5721
[7]   Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis [J].
Hov, Johannes R. ;
Keitel, Verena ;
Laerdahl, Jon K. ;
Spomer, Lina ;
Ellinghaus, Eva ;
ElSharawy, Abdou ;
Melum, Espen ;
Boberg, Kirsten M. ;
Manke, Thomas ;
Balschun, Tobias ;
Schramm, Christoph ;
Bergquist, Annika ;
Weismueller, Tobias ;
Gotthardt, Daniel ;
Rust, Christian ;
Henckaerts, Liesbet ;
Onnie, Clive M. ;
Weersma, Rinse K. ;
Sterneck, Martina ;
Teufel, Andreas ;
Runz, Heiko ;
Stiehl, Adolf ;
Ponsioen, Cyriel Y. ;
Wijmenga, Cisca ;
Vatn, Morten H. ;
Stokkers, Pieter C. F. ;
Vermeire, Severine ;
Mathew, Christopher G. ;
Lie, Benedicte A. ;
Beuers, Ulrich ;
Manns, Michael P. ;
Schreiber, Stefan ;
Schrumpf, Erik ;
Haeussinger, Dieter ;
Franke, Andre ;
Karlsen, Tom H. .
PLOS ONE, 2010, 5 (08)
[8]   Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 [J].
Katsuma, S ;
Hirasawa, A ;
Tsujimoto, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) :386-390
[9]   A G protein-coupled receptor responsive to bile acids [J].
Kawamata, Y ;
Fujii, R ;
Hosoya, M ;
Harada, M ;
Yoshida, H ;
Miwa, M ;
Fukusumi, S ;
Habata, Y ;
Itoh, T ;
Shintani, Y ;
Hinuma, S ;
Fujisawa, Y ;
Fujino, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9435-9440
[10]   Expression and function of the bile acid receptor TGR5 in Kupffer cells [J].
Keitel, Verena ;
Donner, Markus ;
Winandy, Stefanie ;
Kubitz, Ralf ;
Haeussinger, Dieter .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (01) :78-84